Guardian Investor Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Guardian Investor Services’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$242K	Buy	1,396 +30	+2%	+$5.43K	0.19%	127
2014 Q4	$253K	Sell	1,366 -37	-3%	-$6.86K	0.2%	122
2014 Q3	$233K	Sell	1,403 -69	-5%	-$11.3K	0.19%	131
2014 Q2	$230K	Sell	1,472 -40	-3%	-$6.32K	0.18%	145
2014 Q1	$230K	Sell	1,512 -52	-3%	-$8.27K	0.18%	142
2013 Q4	$208K	Hold	1,564	–	–	0.16%	155
2013 Q3	$182K	Sell	1,564 -22	-1%	-$2.41K	0.15%	163
2013 Q2	$146K	Buy	+1,586	New	+$153K	0.13%	194

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Guardian Investor Services's ALXN Position: Q1 2015 in Review

Guardian Investor Services increased its Alexion Pharmaceuticals (ALXN) stake by 2.2% in Q1 2015, buying an estimated $5.43K and bringing the position to 1,396 shares worth $242K. The position accounts for 0.19% of the portfolio, ranked #127.

Guardian Investor Services first reported a position in ALXN in Q2 2013 and has held it in 8 quarters since. The position peaked at $253K in Q4 2014. 566 funds tracked by Wall St. Rank hold ALXN as of Q1 2015.

Guardian Investor Services held 1,396 shares of Alexion Pharmaceuticals worth $242K as of Q1 2015.
Guardian Investor Services bought 30 Alexion Pharmaceuticals shares in Q1 2015, an estimated $5.43K.
Alexion Pharmaceuticals made up 0.19% of Guardian Investor Services's portfolio in Q1 2015, its #127 holding.
Guardian Investor Services first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
Guardian Investor Services's Alexion Pharmaceuticals position peaked at $253K in Q4 2014.
566 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.